Thomas Mark G, Smith Alesha J, Tilyard Murray
Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
N Z Med J. 2014 May 23;127(1394):72-84.
Steadily rising rates of antimicrobial resistance, in a range of common bacterial pathogens, are a major threat to human health in New Zealand in the near future. The single largest contributor to this threat is the high level of antimicrobial consumption in New Zealand. Antimicrobial consumption in New Zealand needs to be reduced if we are to slow the spread of antimicrobial-resistant bacteria. Reporting the per capita antimicrobial consumption within each District Health Board (DHB), in relation to targets for reductions from present levels of consumption, could provide an impetus for DHBs to address this threat to the health of their populations.
在新西兰,一系列常见细菌病原体的抗菌药物耐药率不断上升,这在不久的将来对人类健康构成重大威胁。造成这一威胁的最大单一因素是新西兰抗菌药物的高消费量。如果我们要减缓抗菌药物耐药细菌的传播,就需要减少新西兰的抗菌药物消费量。报告每个地区卫生委员会(DHB)的人均抗菌药物消费量,并与从当前消费水平降低的目标相关联,这可能会促使各地区卫生委员会应对这一对其人口健康的威胁。